Pharma.Aero announces two new additions to the Life Sciences Manufacturers Advisory Platform, now comprising 11 pharmaceutical manufacturers.

Galapagos and associates from Johnson & Johnson are now part of the manufacturers’ cluster. With a rich history in biotechnology and a steadfast commitment to advancing transformative medicines, both members bring a wealth of expertise and innovation to the global collaborative network. By signing up for the LMAP, they join a select group of industry leaders within the Life Sciences Manufacturers Advisory Platform: MSD, Pfizer, Zoetis, Novartis, Bayer, Astra Zeneca’s Alexion, GSK, Euromed Pharma and Germinare.

Victoria Wilmore, Supply Chain Director from Johnson & Johnson: “Being a part of a world-class group of life science manufacturers with unwavering collaboration from the supply chain community is invaluable.  This will help us better serve the patients who are at the heart of all we do.”

Pharma.Aero created the Life Science Manufacturers Advisory Platform (LMAP) to further engage the manufacturing segment to provide first-line advice on the activities and projects of Pharma.Aero and support the logistics and supply chain industry. The LMAP integrates into all Pharma.Aero cross-industry initiatives and provide content value to the organization.